Observing the Clinical Course of Duchenne Muscular Dystrophy in Medicaid Real-World Healthcare Data

ConclusionsThis study is the first to use diagnosis and procedure codes from real-world Medicaid claims to document the clinical course in DMD. Findings were consistent with previously published estimates from commercially insured populations and clinical registries; and contribute to the expanding body of real-world evidence around clinical progression of patients with DMD.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research